节点文献

新生儿接种不同种类乙型肝炎疫苗安全性和免疫应答的研究

Study on Safety and Immunologic Response with Different Hepatitis B Vaccine of Primary Vaccination for Infants

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 周绍英边国林马瑞倪红霞董红军史宏辉胡丹标

【Author】 ZHOU Shao-ying,BIAN Guo-lin,MA Rui,et al.(Ningbo Municipal Center for Disease Control and Prevention,Ningbo 315010,Zhejiang,China)

【机构】 宁波市疾病预防控制中心余姚市疾病预防控制中心宁海县疾病预防控制中心

【摘要】 目的了解新生儿接种不同种类乙型肝炎(乙肝)疫苗(Hepatitis B Vaccine,HepB)的安全性和免疫应答。方法选择浙江省余姚市、宁海县2009年7月1日~12月31日在本地产院分娩的新生儿,分别按0、1、6个月免疫程序接种10微克(g)重组HepB(汉逊酵母)[HepB Made by Recombinant Deoxyribonucleic Acid(DNA)Techniques in Hansenula Polymorpha Yeast,HepB-HPY]和5g重组HepB(酿酒酵母)[HepB Made by RecombinantDNA Techniques in Saccharomyces Cerevisiae Yeast,HepB-SCY],在接种后7d进行安全性评价,并对母亲乙肝病毒表面抗原[Hepatitis B Virus(HBV)Surface Antigen,HBsAg]阴性的本地新生儿全程免疫后1个月及6个月,分别采集血标本进行免疫应答评价。结果 5g HepB-SCY和10g HepB-HPY不良反应发生率分别为44.16/10万和35.74/10万,差异无统计学意义。在全程接种后1个月及6个月,5g HepB-SCY和l0g HepB-HPY的抗乙肝病毒表面抗原抗体(Antibody to HBsAg,Anti-HBs)阳性率分别为99.81%、98.26%和99.81%、99.22%,差异无统计学意义;Anti-HBs的几何平均浓度(Geometry Mean Concentration,GMC)分别为762.71毫国际单位/毫升(mIU/ml)、257.59mIU/ml和2796.82mIU/ml、704.02mIU/ml,差异有统计学意义,10g HepB-HPY组均高于5g HepB-SCY组。Anti-HBs低/无应答(<100mIU/ml)率分别为5.61%、23.60%和1.36%、5.04%,差异有统计学意义,5g HepB-SCY组均高于10g HepB-HPY组。结论 10g HepB-HPY具有与5g HepB-SCY相同的安全性,但免疫应答优于5g HepB-SCY。

【Abstract】 Objective To know the safety and immunologic response with different hepatitis B vaccine(HepB) in infants.Methods The infants born from July 1,2009 to December 31,2009 in Ninghai county received a 0.5ml of 5-μg HepB made by recombinant deoxyribonucleic acid(DNA) techniques in saccharomyces cerevisiae yeast(HepB-SCY)and those in Yuyao received a 0.5ml of 10-μg HepB made by recombinant DNA techniques in hansenula polymorpha yeast(HepB-HPY)(0,1,6 month schedule).Safety was evaluated at 7 days after vaccination.In which,the local infants who accepted 3 doses HepB and born from hepatitis B virus(HBV)surface antigen(HBsAg)negative mother were selected and their blood specimens were collected at 1 month and 6 months after vaccination of 3 doses for testing antibody.Results There was no statistical significant difference about adverse reaction rate of HepB-SCY group(44.16/100,000)and HepB-HPY group(35.74/100,000).At l month and 6 months after vaccination of 3 doses,the antibody to HBsAg(Anti-HBs)positive rate of HepB-SCY group were 99.81%,98.26%and HepB-HPY group were 99.81%,99.22%,no statistical significant difference about HepB-SCY group and HepB-HPY group.The geometric mean concentration(GMC)of Anti-HBs in HepB-SCY group were 762.71mlU/ml,257.59mIU/ml and in HepB-HPY group were 2796.82mIU/ml,704.02mlU/m1.There was statistical significant difference about HepB-SCY group and HepB-HPY group and GMC of HepB-HPY group were higher than that of HepB-SCY group.The percent of <100mIU/ml in HepB-SCY group were 5.61%,23.60%and in HepB-HPY group were 1.36%,5.04%.There was statistical significant difference about HepB-SCY group,and HepB-HPY group,and HepB-SCY group were higher than that of HepB-HPY group.Conclusion The safety was similar with HepB-SCY and HepB-HPY,but the immunologic response of HepB-HPY was better than that of HepB-SCY.

【基金】 国家科学技术“艾滋病和病毒性肝炎等重大传染病防治”重大专项“我国乙型病毒性肝炎流行规律和防治对策研究"课题(编号2008ZXl0002-001)
  • 【文献出处】 中国疫苗和免疫 ,Chinese Journal of Vaccines and Immunization , 编辑部邮箱 ,2012年01期
  • 【分类号】R186
  • 【被引频次】14
  • 【下载频次】164
节点文献中: 

本文链接的文献网络图示:

本文的引文网络